Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology
Second Session, Forty-first Parliament, 2013-14
Chair: The Honourable KELVIN KENNETH OGILVIE
Wednesday, October 1, 2014
Thursday, October 2, 2014
Issue No. 20
Third and fourth meetings on:
Bill C-17, An Act to amend the Food and Drugs Act
WITNESSES
Wednesday, October 1, 2014
Canadian Generic Pharmaceutical Association:
Jim Keon, President.
Consumer Health Products Canada:
Gerry Harrington, Director of Public Affairs.
MEDEC:
Klaus Stitz, Vice President, Regulatory Affairs.
Rx&D:
Walter Robinson, Vice President, Government Affairs;
Jared Rhines, Vice President, Scientific and Strategic Affairs.
Thursday, October 2, 2014
Canadian Pharmacists Association:
Perry Eisenschmid, Chief Executive Officer;
Janet Cooper, Vice President, Professional and Membership Affairs.
HealthCareCAN:
Bill Tholl, President and Chief Executive Officer;
Myrella Roy, Executive Director, Canadian Society of Hospital Pharmacists.
The College of Family Physicians of Canada:
Dr. Jamie Meuser, Executive Director, Continuing Professional Development and Practice Support.
Canadian Institutes of Health Research:
Dr. Robert Peterson, Executive Director, Drug Safety and Effectiveness Network (by video conference).
MEMBERS OF THE COMMITTEE
The Honourable Kelvin Kenneth Ogilvie, Chair
The Honourable Art Eggleton, P.C., Deputy Chair
and
The Honourable Senators:
*Carignan, P.C. (or Martin), Chaput, Cordy, *Cowan (or Fraser), Enverga, Merchant, Nancy Ruth, Seidman, Seth, Stewart Olsen
* Ex officio members
(Quorum 4)